Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

ATM/RB1 mutations predict shorter overall survival in urothelial cancer.

Yin M, Grivas P, Emamekhoo H, Mendiratta P, Ali S, Hsu J, Vasekar M, Drabick JJ, Pal S, Joshi M.

Oncotarget. 2018 Mar 30;9(24):16891-16898. doi: 10.18632/oncotarget.24738. eCollection 2018 Mar 30.

2.

Addition of doxycycline to ciprofloxacin for infection prophylaxis during autologous stem cell transplants for multiple myeloma.

Sivik JM, Davidson J, Hale CM, Drabick JJ, Talamo G.

Support Care Cancer. 2018 Mar 21. doi: 10.1007/s00520-018-4165-6. [Epub ahead of print]

PMID:
29564621
3.

Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice.

Kokolus KM, Zhang Y, Sivik JM, Schmeck C, Zhu J, Repasky EA, Drabick JJ, Schell TD.

Oncoimmunology. 2017 Dec 21;7(3):e1405205. doi: 10.1080/2162402X.2017.1405205. eCollection 2018.

PMID:
29399407
4.

Moving Synergistically Acting Drug Combinations to the Clinic by Comparing Sequential versus Simultaneous Drug Administrations.

Dinavahi SS, Noory MA, Gowda R, Drabick JJ, Berg A, Neves RI, Robertson GP.

Mol Pharmacol. 2018 Mar;93(3):190-196. doi: 10.1124/mol.117.110759. Epub 2017 Dec 14.

PMID:
29242354
5.

Identification of WEE1 as a target to make AKT inhibition more effective in melanoma.

Kuzu OF, Gowda R, Sharma A, Noory MA, Kardos G, Madhunapantula SV, Drabick JJ, Robertson GP.

Cancer Biol Ther. 2018 Jan 2;19(1):53-62. doi: 10.1080/15384047.2017.1360446. Epub 2017 Nov 30.

PMID:
28853983
6.

Molecular Characterization of Bladder Cancer in Smokers versus Nonsmokers.

Joshi M, Millis SZ, Arguello D, Holder SL, Lamm D, Reddy S, Belani C, Drabick JJ, Vogelzang NJ.

Eur Urol Focus. 2018 Jan;4(1):94-97. doi: 10.1016/j.euf.2016.06.011. Epub 2016 Jun 24.

7.

Improving pharmacological targeting of AKT in melanoma.

Kuzu OF, Gowda R, Sharma A, Noory MA, Dinavahi SS, Kardos G, Drabick JJ, Robertson GP.

Cancer Lett. 2017 Sep 28;404:29-36. doi: 10.1016/j.canlet.2017.07.001. Epub 2017 Jul 11.

PMID:
28705772
8.

Prognosis and treatment of non-metastatic primary and secondary breast angiosarcoma: a comparative study.

Yin M, Wang W, Drabick JJ, Harold HA.

BMC Cancer. 2017 Apr 27;17(1):295. doi: 10.1186/s12885-017-3292-7.

9.

PIGN gene expression aberration is associated with genomic instability and leukemic progression in acute myeloid leukemia with myelodysplastic features.

Teye EK, Sido A, Xin P, Finnberg NK, Gokare P, Kawasawa YI, Salzberg AC, Shimko S, Bayerl M, Ehmann WC, Claxton DF, Rybka WB, Drabick JJ, Wang HG, Abraham T, El-Deiry WS, Brodsky RA, J Hohl R, Pu JJ.

Oncotarget. 2017 May 2;8(18):29887-29905. doi: 10.18632/oncotarget.15136.

10.

Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone.

Koller KM, Mackley HB, Liu J, Wagner H, Talamo G, Schell TD, Pameijer C, Neves RI, Anderson B, Kokolus KM, Mallon CA, Drabick JJ.

Cancer Biol Ther. 2017 Jan 2;18(1):36-42. doi: 10.1080/15384047.2016.1264543. Epub 2016 Dec 1.

11.

Malignant melanoma-The cradle of anti-neoplastic immunotherapy.

Koller KM, Wang W, Schell TD, Cozza EM, Kokolus KM, Neves RI, Mackley HB, Pameijer C, Leung A, Anderson B, Mallon CA, Robertson G, Drabick JJ.

Crit Rev Oncol Hematol. 2016 Oct;106:25-54. doi: 10.1016/j.critrevonc.2016.04.010. Epub 2016 May 7. Review.

PMID:
27637351
12.

Primary female breast sarcoma: clinicopathological features, treatment and prognosis.

Yin M, Mackley HB, Drabick JJ, Harvey HA.

Sci Rep. 2016 Aug 11;6:31497. doi: 10.1038/srep31497.

13.

Novel approaches in cancer immunotherapy -- a light at the end of the tunnel.

Joshi M, Pal SK, Drabick JJ.

Discov Med. 2016 Jun;21(118):479-87.

14.

Relationship of smoking status to genomic profile, chemotherapy response and clinical outcome in patients with advanced urothelial carcinoma.

Joshi M, Vasekar M, Grivas P, Emamekhoo H, Hsu J, Miller VA, Stephens PJ, Ali SM, Ross JS, Zhu J, Warrick J, Drabick JJ, Holder SL, Kaag M, Li M, Pal SK.

Oncotarget. 2016 Aug 9;7(32):52442-52449. doi: 10.18632/oncotarget.9449.

15.

Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis.

Yin M, Joshi M, Meijer RP, Glantz M, Holder S, Harvey HA, Kaag M, Fransen van de Putte EE, Horenblas S, Drabick JJ.

Oncologist. 2016 Jun;21(6):708-15. doi: 10.1634/theoncologist.2015-0440. Epub 2016 Apr 6. Review.

16.

Consolidation With Radiation or Concurrent Chemo-Radiation After Chemotherapy Results in Durable Complete Remissions of Isolated Nodal Recurrences of Urothelial Cancer: A Case Series and Review.

Al-Marrawi MY, Mackley HB, Ali S, Wagner H, Joshi M, Holder S, Kaag M, Mallon C, Talamo G, Drabick JJ.

Clin Genitourin Cancer. 2016 Aug;14(4):e393-9. doi: 10.1016/j.clgc.2016.01.004. Epub 2016 Jan 22. No abstract available.

PMID:
26877063
17.

An interstitial deletion within 9p21.3 and extending beyond CDKN2A predisposes to melanoma, neural system tumours and possible haematological malignancies.

Baker MJ, Goldstein AM, Gordon PL, Harbaugh KS, Mackley HB, Glantz MJ, Drabick JJ.

J Med Genet. 2016 Nov;53(11):721-727. doi: 10.1136/jmedgenet-2015-103446. Epub 2016 Jan 21. Review.

PMID:
26794401
18.

A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells.

Matthew EM, Zhou L, Yang Z, Dicker DT, Holder SL, Lim B, Harouaka R, Zheng SY, Drabick JJ, Lamparella NE, Truica CI, El-Deiry WS.

Oncotarget. 2016 Jan 26;7(4):3662-76. doi: 10.18632/oncotarget.6657.

19.

Targeted Therapy in Collecting Duct Carcinoma of the Kidney: A Case Report and Literature Review.

Yin M, Wang W, Rosenberg J, Kaag M, Joshi M, Holder S, Tuanquin L, Drabick JJ.

Clin Genitourin Cancer. 2016 Apr;14(2):e203-6. doi: 10.1016/j.clgc.2015.11.008. Epub 2015 Nov 17. Review. No abstract available.

PMID:
26684811
20.

Symptomatic Secondary Polycythemia Induced by Anti-VEGF Therapy for the Treatment of Metastatic Renal Cell Carcinoma: A Case Series and Review.

Wang W, Cheng J, Mallon C, Al-Marrawi MY, Holder S, Joshi M, Kaag M, Talamo G, Drabick JJ.

Clin Genitourin Cancer. 2015 Dec;13(6):e391-5. doi: 10.1016/j.clgc.2015.07.003. Epub 2015 Jul 26. Review. No abstract available.

PMID:
26303589
21.

Acoustic separation of circulating tumor cells.

Li P, Mao Z, Peng Z, Zhou L, Chen Y, Huang PH, Truica CI, Drabick JJ, El-Deiry WS, Dao M, Suresh S, Huang TJ.

Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):4970-5. doi: 10.1073/pnas.1504484112. Epub 2015 Apr 6.

22.

Durable complete responses off all treatment in patients with metastatic malignant melanoma after sequential immunotherapy followed by a finite course of BRAF inhibitor therapy.

Wyluda EJ, Cheng J, Schell TD, Haley JS, Mallon C, Neves RI, Robertson G, Sivik J, Mackley H, Talamo G, Drabick JJ.

Cancer Biol Ther. 2015;16(5):662-70. doi: 10.1080/15384047.2015.1026507.

23.

Therapeutic approach guided by genetic alteration: use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression.

Lipkin JS, Rizvi SM, Gatalica Z, Sarwani NE, Holder SL, Kaag M, Drabick JJ, Joshi M.

Cancer Biol Ther. 2015;16(1):28-33. doi: 10.4161/15384047.2014.972843.

24.

Effect of topical vaginal androgens in a woman on the testosterone levels of her sexual partner with prostate cancer.

Al-Marrawi MY, Cream LV, Mallon CA, Holder S, Joshi M, Harvey HH, Talamo G, Drabick JJ.

J Clin Oncol. 2015 Feb 10;33(5):521-2. doi: 10.1200/JCO.2014.59.7773. Epub 2015 Jan 5. No abstract available.

PMID:
25559812
25.

Palliative effect of capecitabine and cetuximab for refractory metastatic squamous cell carcinoma of the perineum in epidermodysplasia verruciformis.

Lynch MC, Drabick JJ, Neves RI, Fox EJ, Mackley HB, Anderson BE.

Skinmed. 2014 Jan-Feb;12(1):54-6.

PMID:
24720087
26.

Extraskeletal Ewing's sarcoma arising in the larynx.

Lynch MC, Baker A, Drabick JJ, Williams N, Goldenberg D.

Head Neck Pathol. 2014 Jun;8(2):225-8. doi: 10.1007/s12105-013-0492-6. Epub 2013 Sep 27.

27.

Predicting therapy response in live tumor cells isolated with the flexible micro spring array device.

Gallant JN, Matthew EM, Cheng H, Harouaka R, Lamparella NE, Kunkel M, Yang Z, Harvey HA, Cream LV, Kumar SM, Robertson GP, Zheng S, Drabick JJ, Truica CI, El-Deiry WS.

Cell Cycle. 2013 Jul 1;12(13):2132-43. doi: 10.4161/cc.25165. Epub 2013 Jun 11.

28.

Unusual case of recurrent extraneural metastatic medulloblastoma in a young adult: durable complete remission with Ewing sarcoma chemotherapy regimen and consolidation with autologous bone marrow transplantation and local radiation.

Clement J, Varlotto J, Rybka W, Frauenhoffer E, Drabick JJ.

J Clin Oncol. 2013 Jul 1;31(19):e316-9. doi: 10.1200/JCO.2012.42.6700. Epub 2013 May 28. No abstract available.

PMID:
23715566
29.

Current and future trials of targeted therapies in cutaneous melanoma.

Evans MS, Madhunapantula SV, Robertson GP, Drabick JJ.

Adv Exp Med Biol. 2013;779:223-55. doi: 10.1007/978-1-4614-6176-0_10. Review.

30.

Effects of commercially available soy products on PSA in androgen-deprivation-naïve and castration-resistant prostate cancer.

Joshi M, Agostino NM, Gingrich R, Drabick JJ.

South Med J. 2011 Nov;104(11):736-40. doi: 10.1097/SMJ.0b013e3182335151.

PMID:
22024780
31.

Neoadjuvant concurrent chemoradiation for advanced esthesioneuroblastoma: a case series and review of the literature.

Sohrabi S, Drabick JJ, Crist H, Goldenberg D, Sheehan JM, Mackley HB.

J Clin Oncol. 2011 May 1;29(13):e358-61. doi: 10.1200/JCO.2010.30.9278. Epub 2011 Jan 31. No abstract available.

PMID:
21282533
32.

Poking CD40 for cancer therapy, another example of the Goldilocks effect.

Drabick JJ, Schell TD.

Cancer Biol Ther. 2010 Nov 15;10(10):994-6. Epub 2010 Nov 15. No abstract available.

PMID:
21057206
33.
34.
35.

Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice.

Agostino NM, Chinchilli VM, Lynch CJ, Koszyk-Szewczyk A, Gingrich R, Sivik J, Drabick JJ.

J Oncol Pharm Pract. 2011 Sep;17(3):197-202. doi: 10.1177/1078155210378913. Epub 2010 Aug 4.

PMID:
20685771
36.

Significant activity of single agent vinorelbine against small-cell cancer of the bladder as second line chemotherapy: a case series and review of the literature.

June RR, Dougherty DW, Reese CT, Harpster LE, Hoffman SL, Drabick JJ.

Urol Oncol. 2012 Mar-Apr;30(2):192-5. doi: 10.1016/j.urolonc.2009.12.017. Epub 2010 Apr 3. Review.

PMID:
20363163
37.

Guillain-Barré syndrome after use of alemtuzumab (Campath) in a patient with T-cell prolymphocytic leukemia: a case report and review of the literature.

Abbi KK, Rizvi SM, Sivik J, Thyagarajan S, Loughran T, Drabick JJ.

Leuk Res. 2010 Jul;34(7):e154-6. doi: 10.1016/j.leukres.2010.02.036. Epub 2010 Apr 2. No abstract available.

PMID:
20362332
38.

Retroperitoneal diffuse large B-cell lymphoma presenting as pseudoachalasia.

Pastor DM, Eggers AD, Drabick JJ, Loughran TP, Bayerl MG, Shope TR.

J Clin Oncol. 2010 Apr 20;28(12):e184-7. doi: 10.1200/JCO.2009.25.8715. Epub 2010 Mar 15. No abstract available.

PMID:
20231681
39.

Epstein Barré virus-negative diffuse large B-cell lymphoma in an HIV-infected man with a durable complete remission on highly active antiretroviral therapy alone.

Koszyk-Szewczyk A, Bayerl M, Zurlo J, Drabick JJ.

South Med J. 2010 Jan;103(1):76-80. doi: 10.1097/SMJ.0b013e3181c48001.

PMID:
19996843
40.

Pulmonary crystal-storing histiocytosis diagnosed by computed tomography-guided fine-needle aspiration.

Todd WU, Drabick JJ, Benninghoff MG, Frauenhoffer EE, Zander DS.

Diagn Cytopathol. 2010 Apr;38(4):274-8. doi: 10.1002/dc.21193.

PMID:
19845034
41.

BU and CY as conditioning regimen for autologous transplant in patients with multiple myeloma.

Talamo G, Claxton DF, Dougherty DW, Ehmann CW, Sivik J, Drabick JJ, Rybka W.

Bone Marrow Transplant. 2009 Aug;44(3):157-61. doi: 10.1038/bmt.2008.446. Epub 2009 Feb 9.

PMID:
19204716
42.

Superficial bladder cancer metastatic to the lungs: two case reports and review of the literature.

Dougherty DW, Gonsorcik VK, Harpster LE, Trussell JC, Drabick JJ.

Urology. 2009 Jan;73(1):210.e3-5. doi: 10.1016/j.urology.2008.01.050. Epub 2008 Apr 18. Review.

PMID:
18372021
43.

Xp11 translocation renal cell carcinoma: delayed but massive and lethal metastases of a chemotherapy-associated secondary malignancy.

Rais-Bahrami S, Drabick JJ, De Marzo AM, Hicks J, Ho C, Caroe AE, Argani P.

Urology. 2007 Jul;70(1):178.e3-6.

PMID:
17656236
44.

Eruptive latent metastatic melanomas after initiation of antitumor necrosis factor therapies.

Fulchiero GJ Jr, Salvaggio H, Drabick JJ, Staveley-O'Carroll K, Billingsley EM, Marks JG, Helm KF.

J Am Acad Dermatol. 2007 May;56(5 Suppl):S65-7.

PMID:
17434043
45.

Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjogren's syndrome.

Harner KC, Jackson LW, Drabick JJ.

Rheumatology (Oxford). 2004 Oct;43(10):1309-10. No abstract available.

PMID:
15448217
46.

Phase I study of detoxified Escherichia coli J5 lipopolysaccharide (J5dLPS)/group B meningococcal outer membrane protein (OMP) complex vaccine in human subjects.

Cross AS, Opal SM, Palardy JE, Drabick JJ, Warren HS, Huber C, Cook P, Bhattacharjee AK.

Vaccine. 2003 Nov 7;21(31):4576-87.

PMID:
14575770
47.

Proinflammatory syndrome mimicking acute rheumatoid arthritis in a patient with Waldenstrom's macroglobulinemia treated with rituximab.

Buda-Okreglak EM, Drabick JJ, Delaney NR.

Ann Hematol. 2004 Feb;83(2):117-9. Epub 2003 Sep 25.

PMID:
14513285
48.
49.

Human herpesvirus 8 genome is not found in whole bone marrow core biopsy specimens of patients with plasma cell dyscrasias.

Drabick JJ, Davis BJ, Lichy JH, Flynn J, Byrd JC.

Ann Hematol. 2002 Jun;81(6):304-7. Epub 2002 May 25.

PMID:
12107558
50.

Concurrent pernicious anemia and myelodysplastic syndrome.

Drabick JJ, Davis BJ, Byrd JC.

Ann Hematol. 2001 Apr;80(4):243-5.

PMID:
11401093

Supplemental Content

Loading ...
Support Center